Oramed Patent Allowed in the US for Oral Administration of Proteins
NEW YORK, May 30, 2018 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a developer of oral drug delivery systems, announced today that the Company’s patent for its invention, titled “Methods and Compositions for Oral Administrations of Proteins,” has been allowed by the United States Patent and Trademark Office. Nadav Kidron, CEO of […]
